Skin-whitening agent and reductant for skin care
Aqueous dispersions of smectite clay minerals provide a stable and effective solution for inhibiting melanin accumulation, addressing the limitations of existing skin whitening agents by enhancing safety and longevity of melanin suppression.
Patent Information
- Application Number
- JP2023071696
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-04-25
- Publication Date
- 2024-11-07
AI Technical Summary
Existing skin whitening agents like hydroquinone and ascorbic acid lack stability and efficacy in suppressing melanin accumulation over a long period, leading to aesthetically undesirable conditions such as age spots and freckles.
Aqueous dispersions of smectite clay minerals are used as active ingredients in skin care products, providing strong reducing power and stability to inhibit melanin accumulation.
The clay minerals effectively suppress melanin production and decolorize existing melanin, offering a safe and long-lasting whitening effect.
Smart Images

Figure 2024157370000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a skin whitening agent and a reducing agent for skin care. [Background technology]
[0002] When the skin is exposed to ultraviolet rays, active oxygen causes melanin synthesis in melanocytes (pigment cells) in the skin. Excessive synthesis of melanin locally or melanin deposition due to disturbance in cell turnover can result in liver spots (age spots) and freckles, which are considered undesirable from a cosmetic standpoint. As shown in Figure 1, there are two types of melanin biosynthesis pathways, eumelanin (black melanin) and pheomelanin (reddish-brown melanin), and eumelanin is the cause of the above-mentioned age spots and freckles. In this biosynthesis pathway, tyrosine, an amino acid, is used as the starting material, and is converted to dopa and dopaquinone by the action of tyrosinase. Then, via dopachrome, an oxidation reaction proceeds, and eumelanin is synthesized by polymerization of the oxide. For this reason, active development is being carried out on compounds that inhibit the synthesis pathway from tyrosine to eumelanin, and compounds that can reduce accumulated eumelanin (oxidized melanin) to light-colored reduced melanin. For example, ascorbic acid (vitamin C) is known to inhibit the activity of tyrosinase, and is also known to be able to reduce eumelanin to light-colored reduced melanin. In addition, hydroquinone not only inhibits the activity of tyrosinase, but also reduces the number of melanocytes, and is used as a powerful whitening agent.
[0003] As described above, it has been reported that hydroquinone and ascorbic acid can suppress the accumulation of melanin, but they are poor in stability and cannot exert the effect of suppressing the accumulation of melanin for a long period of time. Therefore, research and development is being conducted to improve the stability of whitening agents such as hydroquinone. For example, Patent Document 1 discloses a hydroquinone-containing skin preparation that is characterized by having hydroquinone, a polyhydric alcohol, a water-swellable clay mineral, an oily component, a stabilizer, and water, and shows that the stability of hydroquinone is improved in the skin preparation.In addition, in the skin preparation, the water-swellable clay mineral is used as an emulsifier for W / O preparation (water-in-oil preparation). [Prior art documents] [Patent documents]
[0004] [Patent Document 1] Patent Publication No. 2022-112595 Summary of the Invention [Problem to be solved by the invention]
[0005] An object of the present invention is to provide a skin whitening agent and a reducing agent for skin care which are highly safe to the living body, have excellent stability, and can inhibit the accumulation of melanin for a long period of time. [Means for solving the problem]
[0006] In view of the above problems, the present inventors have conducted extensive research and have found that an aqueous dispersion of smectite, which has a proven track record of use as a thickener or emulsifier in the field of cosmetics and is highly safe for the human body, has a strong reducing effect. They have also found that this reducing effect can stably suppress the accumulation of melanin over a long period of time. The present invention has been completed based on these findings.
[0007] That is, the above-mentioned object of the present invention has been achieved by the following means. [1] A skin whitening agent that contains clay minerals as an active ingredient. [2] A reducing agent for skin care that contains clay minerals as an active ingredient. [3] The agent according to [1] or [2] above, wherein the clay mineral inhibits accumulation of melanin. [4] The agent according to any one of [1] to [3] above, wherein the clay mineral is a clay mineral having an oxidation-reduction potential of a 2 mass % aqueous dispersion of the clay mineral of 0.33 V vs. SHE or less. [5] The agent according to any one of [1] to [4] above, wherein the clay mineral comprises smectite. [6] A cosmetic comprising the agent according to any one of [1] to [5] above. [7] The cosmetic product according to [6] above, wherein the content of the clay mineral is 0.05 to 30 mass %. [8] The cosmetic according to [6] or [7] above, which contains an acidic reducing agent.
[0008] The skin whitening agent and reducing agent for skin care of the present invention are highly safe for the human body, have strong reducing power, and can inhibit the accumulation of melanin for a long period of time. [Brief description of the drawings]
[0009] [Figure 1] FIG. 1 is a schematic diagram of the melanin biosynthetic pathway. [Diagram 2] FIG. 1 is a schematic diagram of an apparatus used for measuring an oxidation-reduction potential. [Diagram 3] 13 is a photograph substituting a drawing showing the state of melanin accumulation on the 15th day after the reaction. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Preferred embodiments of the present invention will be described below in detail, but the present invention is not limited to these embodiments except as specified in the present invention.
[0011] [Whitening agents, reducing agents for skin care] The whitening agent and reducing agent for skin care of the present invention (hereinafter, these are also collectively referred to simply as "the agent of the present invention") contain a clay mineral as an active ingredient. Due to the action of the clay mineral, the agent of the present invention exhibits weak alkalinity when dispersed in water, while also exhibiting a strong reducing action. Therefore, due to the reducing action, it is possible to suppress the accumulation of melanin and exert a whitening effect. In addition, in the present invention and this specification, "melanin" is a general term for eumelanin, pheomelanin, etc., and the melanin is preferably eumelanin. The agent of the present invention is assumed to have both a function of suppressing melanin production and a function of reducing and decolorizing the produced melanin (eumelanin). As shown in FIG. 1, eumelanin is synthesized by a series of oxidation reactions starting from tyrosine, so it is believed that the strong reducing action of the agent of the present invention can suppress the production of melanin (eumelanin) and suppress the accumulation of melanin to exert a whitening effect. In addition, the produced eumelanin (oxidized melanin) is called black melanin, which causes spots and freckles, while the reduced melanin obtained by reducing black melanin exhibits a light color. Therefore, it is believed that by reducing and decolorizing oxidized melanin with the agent of the present invention, the accumulation of black melanin can be suppressed and a whitening effect can be exerted. The characteristic features of the agent of the present invention will be described below.
[0012] (Clay Minerals) In the agent of the present invention, the clay mineral is preferably smectite. The type of smectite is not particularly limited and can be appropriately set according to the purpose. Natural smectite or synthetic smectite can also be used, and it is preferable to use synthetic smectite from the viewpoint of low impurity content. The synthetic smectite may be smectite having hydroxyl groups at the crystal end, or fluorinated smectite in which the hydroxyl groups are replaced by fluorine atoms. Synthetic smectite can be produced by a conventional method. The smectite is preferably one or more selected from montmorillonite, beidellite, nontronite, saponite, hectorite, fluorohectorite, sauconite, and stevensite, and more preferably one or more selected from saponite, hectorite, fluorohectorite, and stevensite.
[0013] The interlayer cation species of the smectite is not particularly limited, but is preferably sodium ion or lithium ion. By using sodium ion or lithium ion as the interlayer cation, for example, when the clay mineral is dispersed in an aqueous medium, it is possible to impart excellent swelling property and dispersion stability. The cation exchange capacity (CEC) of the smectite is preferably 15 meq (milli-equivalent) / 100 g or more, more preferably 20 meq / 100 g or more, and even more preferably 25 meq / 100 g or more, from the viewpoint of improving the swelling property during dispersion. The cation exchange capacity of the smectite that can be used in the present invention is usually 250 meq / 100 g or less.
[0014] The particle size of the clay mineral is not particularly limited and can be appropriately set according to the purpose. For example, the particle size (primary particle size) of the clay mineral can be 20 to 500 nm, 30 to 400 nm, 40 to 380 nm, or 50 to 370 nm. In the present invention, the "particle size" of the clay mineral in the dispersion liquid is a volume-based median size. This particle size can be determined, for example, by a laser diffraction / scattering type particle size distribution measuring device.
[0015] In the agent of the present invention, the content of the clay mineral is not particularly limited, and can be appropriately set according to the type of cosmetics to which the agent of the present invention is applied.The content is preferably 30% by mass or more, more preferably 50% by mass or more, even more preferably 80% by mass or more, even more preferably 85% by mass or more, even more preferably 90% by mass or more, even more preferably 95% by mass or more, even more preferably 98% by mass or more, and even more preferably 99% by mass or more.In addition, the entire agent of the present invention may be the clay mineral, but it is usually practical to use 99% by mass or less.
[0016] (Other Ingredients) The agent of the present invention may contain other components such as additives within a range that does not impair the effects of the present invention. Examples of additives include pH adjusters, moisturizers, antioxidants, fragrances, various vitamin preparations, chelating agents, colorants, medicinal ingredients, inorganic salts, ingredients with preservative effects, and ingredients useful for skin care products such as plant extracts. Furthermore, stabilizers, defoamers, specific gravity adjusters, viscosity adjusters, organic solvents, surfactants, emollients, pigments, ultraviolet absorbers, and ultraviolet scattering agents may be used in combination. The additives may be used alone or in combination of two or more. The content of the additive in the agent of the present invention is preferably 0.01 to 10% by mass per additive.
[0017] (liquid medium) The agent of the present invention can also be a dispersion liquid in which clay mineral is dispersed in a liquid medium. Such a liquid medium is not particularly limited, and various liquid media that can uniformly disperse clay mineral can be used. Among them, from the viewpoint of the dispersion stability of clay mineral, the liquid medium is preferably an aqueous medium such as water or an aqueous solution, and more preferably water. In addition, the liquid medium may be a liquid medium containing the above-mentioned other components. The water is not particularly limited, and may be tap water or purified water such as distilled water or ion-exchanged water. From the viewpoint of dispersion stability, purified water from which ions in the water have been removed is particularly preferable. In this case, the ionic conductivity of the water is preferably 10 μS / m or less, more preferably 5 μS / m or less, and even more preferably 2 μS / m or less. When the agent of the present invention is a dispersion obtained by dispersing it in water, the content of the clay mineral in the dispersion is not particularly limited, but from the viewpoints of ease of handling and exerting a whitening effect, it is preferably 0.1 to 30 mass%, can be 0.5 to 20 mass%, or can be 1 to 15 mass%.
[0018] <Oxidation-reduction potential> The agent of the present invention has a strong reducing power due to the clay mineral as an active ingredient. This reducing power can be determined by measuring the redox potential against a standard hydrogen electrode (SHE), and generally, a lower redox potential means a higher reducing power. The redox potential of the clay mineral as an active ingredient of the present invention is preferably 0.33 V or less (0.33 V [vs. SHE] or less) against SHE when the clay mineral is dispersed in water (purified water) to form a dispersion liquid with a clay mineral concentration of 2 mass% (solid content concentration), more preferably 0.30 V or less (0.30 V [vs. SHE] or less), and even more preferably 0.28 V or less (0.28 V [vs. SHE] or less).
[0019] The redox potential of the clay mineral, which is an active ingredient of the agent of the present invention, can be measured, for example, by the following method. Figure 2 shows a schematic diagram of an apparatus for measuring the redox potential. A glass cell 1 is filled with a dispersion liquid 2 in which the clay mineral, which is an active ingredient of the present invention, is dispersed in water (purified water) to a clay mineral concentration of 2 mass% (solid content concentration), and a platinum electrode (Pt) 3 is immersed in this cell as a working electrode. In addition, a buffer solution 4 of pH 10 is filled in another glass cell, and a mercury-mercury oxide electrode (Hg / HgO) 5 having a redox potential of +0.1 V relative to a standard hydrogen electrode (SHE) is immersed in this cell as a reference electrode. Furthermore, these two cells are connected with a salt bridge 6. At 25°C, the working electrode and the reference electrode are each connected to a potentiometer 7, and then the potential difference after standing for 5 minutes ([voltage at the working electrode terminal] - [voltage at the reference electrode terminal]) is read, and the redox potential relative to SHE (V [vs. SHE]) can be calculated by adding 0.1 V, which is a correction value for SHE, to the potential difference value.
[0020] <ph> The pH of the agent of the present invention is not particularly limited, and from the viewpoint of safety to the human body and handling such as disposal, for example, in the case of a dispersion liquid with a clay mineral concentration of 2 mass% (solid content concentration), it is preferable that the pH is weakly acidic to weakly alkaline, that is, pH 3.0 to 11.0, under room temperature (25°C) conditions. For example, when smectite in which the interlayer cation is sodium ion or lithium ion is dispersed in water as it is, the pH is often about 8 to 11, which is in the weak alkaline range. When such smectite is used as the clay mineral contained in the present invention, it can be used as it is as the agent of the present invention without adjusting the pH. In addition, since the pH of human skin is generally considered to be weakly acidic, ranging from 4.5 to 6.5, a pH adjuster can be added to the agent of the present invention to adjust the pH range of the dispersion in which the agent of the present invention is dispersed to fall within the weakly acidic range. The acidic compound used as the pH adjuster may be, for example, an organic acid, which is an acidic organic compound having a carboxyl group or a phosphate group, or an inorganic acid (mineral acid) such as hydrochloric acid, sulfuric acid, or nitric acid. In addition, it may be an acidic compound having reducing power (an acidic reducing agent, for example, ascorbic acid or a salt thereof). The pH adjuster may be contained in the cosmetic product described below.
[0021] <Viscosity> Some general cosmetics contain thickeners such as cellulose compounds in order to improve the adhesion of the cosmetics to the skin. The agent of the present invention has a suitable viscosity when dispersed in an aqueous medium due to the clay mineral as an active ingredient. Therefore, for example, when the agent of the present invention is blended in cosmetics, the cosmetics can have a suitable viscosity without adding a thickener. The clay mineral, which is the active ingredient of the agent of the present invention, when dispersed in water at a concentration of 2% by mass (solid content concentration), preferably has a viscosity of 10 mPa·s or more, more preferably 100 mPa·s or more, even more preferably 500 mPa·s or more, and even more preferably 1000 mPa·s or more at 25° C. From the viewpoint of handleability as a liquid, the viscosity is preferably 200,000 mPa·s or less, more preferably 100,000 mPa·s or less, even more preferably 10,000 mPa·s or less, and even more preferably 5,000 mPa·s or less.
[0022] The viscosity can be measured, for example, using a Brookfield (B-type) viscometer at a measurement temperature of 25° C. using a rotor suitable for the measurement viscosity range, and rotating at 12 rpm, 60 seconds after the start of rotation.
[0023] [cosmetics] The agent of the present invention is preferably used by being contained (blended) in cosmetics and the like. That is, it can be a whitening cosmetic or a reducing cosmetic for skin care (a cosmetic having a reducing action) containing the agent of the present invention. In the present invention and this specification, "cosmetics" refers to cosmetics that can contain the agent of the present invention. For example, it includes various cosmetics or cosmetic preparations such as makeup (finishing) cosmetics, skin cosmetics, bath cosmetics, and body powder. Among them, the above-mentioned cosmetics are preferably skin cosmetics. Examples of the skin cosmetics include lotions, cosmetic liquids, creams, milky lotions, suntan cosmetics, sunscreen cosmetics, cleansers, and packs. In addition, when the agent of the present invention is a dispersion liquid obtained by dispersing a clay mineral in water or the like as explained above, the dispersion liquid (agent) itself can be used as the above-mentioned cosmetic product or the like.
[0024] In the cosmetic, the content of the clay mineral in the cosmetic is not particularly limited and can be set appropriately depending on the type of cosmetic, and is preferably 0.05 to 30 mass%, more preferably 0.1 to 25 mass%, even more preferably 0.5 to 20 mass%, and even more preferably 1 to 15 mass%. The cosmetic product may also contain other ingredients as described above.
[0025] In addition, since the agent of the present invention contains a clay mineral as an active ingredient, it also functions as a surfactant. Therefore, by blending the agent of the present invention in the cosmetic product, the amount of other surfactants added can be reduced or even omitted. EXAMPLES
[0026] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.
[0027] <Preparation example of test solution> The materials used in the preparation of each test solution are as follows. Note that the interlayer ions in the clay minerals listed below are all sodium ions. (Clay Minerals) Sumecton-ST (product name): synthetic clay, Stevensite, cation exchange capacity 25 meq / 100 g, average primary particle size 35 nm, manufactured by Kunimine Kogyo Co., Ltd. Sumecton-SWN (trade name): synthetic clay, hectorite, cation exchange capacity 43 meq / 100 g, average primary particle size 75 nm, manufactured by Kunimine Kogyo Co., Ltd. Sumecton-SWF (product name): synthetic clay, fluorohectorite, cation exchange capacity 70 meq / 100 g, average primary particle size 90 nm, manufactured by Kunimine Kogyo Co., Ltd. Sumecton-SA (product name): synthetic clay, saponite, cation exchange capacity 66 meq / 100 g, average primary particle size 100 nm, manufactured by Kunimine Kogyo Co., Ltd. (skin whitening agent) Hydroquinone: Special grade, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd. Sodium L-ascorbate: Special grade, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd. (pH adjuster) Sodium hydroxide: Special grade, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd. Sodium bicarbonate: Special grade, manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.
[0028] (Examples 1 to 4) The clay minerals shown in Table 1 below were dispersed in distilled water (electrical conductivity 0.2 μS / cm or less) in the blending ratios shown in Table 1, respectively, to prepare the test solutions of Examples 1 to 4.
[0029] Comparative Example 1 In accordance with the method described in JIS K8001:2017, a buffer solution (pH 10, which is approximately the same as the pH of each Example) was prepared using a sodium hydroxide solution and a sodium bicarbonate solution obtained by dissolving the sodium hydroxide reagent and the sodium bicarbonate reagent in the distilled water, and the buffer solution was used as the test liquid for Comparative Example 1.
[0030] (Reference example 1) Hydroquinone, a known skin whitening agent, was dissolved in the distilled water in the blending ratio shown in Table 1 to prepare an aqueous solution. This aqueous solution was used as the test liquid of Reference Example 1.
[0031] (Reference example 2) Sodium L-ascorbate, a known skin whitening agent, was dissolved in the distilled water in the blending ratio shown in Table 1 to prepare an aqueous solution, which was used as the test liquid of Reference Example 2.
[0032] <Test Example> Using the obtained test solutions of Examples 1 to 4, Comparative Example 1, and Reference Examples 1 and 2, the following tests were carried out.
[0033] (pH measurement) The pH (25° C.) of each of the test solutions in Examples 1 to 4, Comparative Example 1, and Reference Examples 1 and 2 was measured using a pH meter (model number: LAQUAtwin-pH-33B, manufactured by Horiba, Ltd.) The results are shown in Table 1 below.
[0034] (Oxidation-reduction potential measurement) A schematic diagram of the redox potential measuring device is shown in Figure 2. The internal volume is 20 cm 3 The glass cell was filled with each of the test solutions of Examples 1 to 4, Comparative Example 1, and Reference Examples 1 and 2 up to 80% of the volume, and a platinum electrode (product name: Pt Counter Electrode 5.7 cm, manufactured by BAS) was immersed in the cell by 4 cm as a working electrode. 3 The glass cell was filled with the same pH 10 buffer solution as in Comparative Example 1 up to 80% of the volume, and a mercury-mercury oxide electrode (RE-2BP, manufactured by BAS) with a redox potential of +0.1 V relative to the standard hydrogen electrode (SHE) was immersed 4 cm into the cell as a reference electrode. To ionically connect these two cells, a filter paper moistened with the pH 10 buffer solution was placed as a salt bridge. At 25°C, the working electrode and the reference electrode were connected to a potentiometer (electrochemical measurement device ALS600, manufactured by BAS), and the potential difference ([working electrode terminal voltage] - [reference electrode terminal voltage]) was read after leaving it for 5 minutes, and the redox potential relative to SHE (V [vs. SHE]) was calculated by adding 0.1 V to the potential difference. The results are shown in Table 1 below.
[0035] (Melanin accumulation evaluation test) It is known that the enzyme tyrosinase contained in potatoes oxidizes tyrosine, an amino acid, to produce dopa and dopaquinone, which in turn undergo a series of subsequent oxidation reactions to ultimately produce black-brown melanin (eumelanin). When potatoes are cut and left to stand, the cut surface turns brown (black) as the reaction catalyzed by tyrosinase progresses and melanin is produced. Taking advantage of this property, the effect of the above test solution in inhibiting melanin accumulation was tested using potatoes. The potatoes were grated with a grater, wrapped in nonwoven fabric, and the juice was squeezed out. 10 g of the obtained potato juice was transferred to a test tube, and 2 g of each of the test solutions of Examples 1 to 4, Comparative Example 1, and Reference Examples 1 and 2 was added to prepare a reaction solution, which was then allowed to stand at 25°C. The change in color tone of the reaction solution on the 4th and 15th days after the reaction was observed visually. As a standard for the change in color tone, 12 g of potato juice to which no test solution had been added was placed in a test tube and similarly allowed to stand at 25°C, and used as a standard solution for judging the color tone on the 4th and 15th days in the above test. Each reaction solution on the 4th and 15th days after the reaction was evaluated according to the following evaluation criteria, using the color tone of the standard solution as the standard. The results are shown in Table 1 below. Also, a photograph of the appearance of the reaction solution on the 15th day after the reaction is shown in FIG. 2. -Evaluation criteria- ◎: Less brown than the reference solution. ○: The brown color is slightly lighter than that of the reference solution. △: Same degree of brown color as the reference solution. ×: The color is darker brown than the reference solution.
[0036] [Table 1]
[0037] The test solution of Comparative Example 1, which used a buffer solution of pH 10 as the test solution, had a slightly high redox potential of 0.36. The reaction solution to which the test solution was added showed the same brown color as the reference solution on the 4th and 15th days after standing. As shown in FIG. 3, the reaction solution of Comparative Example 1 showed the same brown color as the reference solution. This revealed that the alkaline solution itself, which has an alkaline pH, does not have an effect of suppressing melanin accumulation. In addition, in the reaction solution of Reference Example 1 using hydroquinone as the test solution, the reaction solution turned black on both the 4th and 15th days after standing. This indicates that hydroquinone is unstable and is converted into black quinhydrone. In addition, in the reaction solution of Reference Example 2 using sodium L-ascorbate as the test solution, the degree of browning was lighter than that of the standard solution on the 4th day after standing, but the degree of browning was slightly lighter than that of the standard solution on the 15th day after standing. This indicates that the accumulation of melanin was inhibited by the action of sodium L-ascorbate, and that the effect of sodium L-ascorbate in inhibiting the accumulation of melanin was weakened by the long-term reaction. In contrast, the test solutions of Examples 1 to 4, which used an aqueous dispersion of smectite as the test solution, all had a pH of around 10 and an oxidation-reduction potential of 0.33 V [vs. SHE] or less. Furthermore, the reaction solutions to which the test solutions were added were slightly less brown than the reference solution on the fourth day after standing (Example 4) or less brown (Examples 1 to 3), and even on the 15th day after standing, were less brown than the reference solution (Examples 1 to 4). This indicates that smectite was able to suppress the accumulation of melanin over a long period of 15 days after the reaction. [Explanation of symbols]
[0038] 1. Glass cell 2 Dispersion 3 Platinum electrode 4 Buffer 5. Mercury-mercury oxide electrode 6. Salt Bridge 7 Potentiometer< / ph>
Claims
1. A skin whitening agent that contains clay minerals as an active ingredient.
2. A reducing agent for skin care that contains clay minerals as an active ingredient.
3. The agent according to claim 1 or 2, wherein the clay mineral inhibits accumulation of melanin.
4. The agent according to claim 1 or 2, wherein the clay mineral has an oxidation-reduction potential of a 2% by mass aqueous dispersion of the clay mineral of 0.33 V vs. SHE or less.
5. The agent according to claim 1 or 2, wherein the clay mineral comprises smectite.
6. A cosmetic comprising the agent according to claim 1 or 2.
7. The cosmetic product according to claim 6, wherein the content of the clay mineral is 0.05 to 30% by mass.
8. The cosmetic product according to claim 6, which contains an acidic reducing agent.
Citation Information
Patent Citations
Quantum / ion nutritional solution for nourishing and restoring surface cells of human body as well as preparation method and application of quantum / ion nutritional solution
CN108653164A
Gel-like mist composition
JP2003137729A
Face lotion or cosmetic produced by using weakly acidic concentrated mineral liquid as stock water
JP2006069974A
Pack cosmetic
JP2007070246A
Skin preparation for external use
JP2009062311A
